Our work generating a comprehensive epigenomic atlas in clear cell renal cell carcinoma, informing kidney cancer progression and heritability, was published in Cell Reports. LINK
Our work on cell-free DNA epigenomic profiling for the noninvasive detection and monitoring of translocation renal cell carcinoma was published in the Journal of Clinical Investigation. LINK
We're excited to welcome Ali Hajj Ali to the team as a research fellow!
Our research fellow Liliana Ascione presented a session at the ESMO Advanced Course on ADC age-related toxicity prediction, identification, and treatment in Zurich. LINK
January 2026
Our work on outcomes of patients with metastatic non-clear cell RCC receiving contemporary first-line therapies, based on data from the IMDC, was published in European Urology Oncology. LINK
Our work on soluble MAdCAM-1 as a prognostic biomarker in metastatic RCC was published in Nature Medicine. LINK
December 2025
AUC3's expert consensus recommendations for the management of RCC and urinary tract cancers from the 2025 Advanced Urologic Cancer Consensus Conference was published in CA: A Cancer journal for clinicians. LINK
Congratulations to our previous postdoctoral research fellows Chris Labaki and Talal Zarif on matching for their Oncology and Cardiology Fellowships at Johns Hopkins and UCLA.
We're excited to welcome Tarek Baroud to the team as a research fellow!
November 2025
Congratulations to our postdoctoral research fellow Pablo Moura Barrios on completing the Boston half marathon in support of Dana-Farber and the Jimmy Fund!
Our work on targeting HIF-2 driven cachexia in kidney cancer was published in Nature Medicine. LINK
October 2025
Our paper showing how myeloid cells mediate interferon-driven resistance to immunotherapy in RCC was published in Immunity. LINK
Our work evaluating humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients was published in Human Vaccines & Immunotherapeutics. LINK
We're excited to welcome our new postdoctoral research fellow, Sara El Sarout, to the team!
Congratulations to our postdoctoral research fellows Clara Steiner and Marc Machaalani for being selected for Merit Awards for their ESMO 2025 Congress abstracts!
Our research fellows Marc Machaalani and Eddy Saad delivered Oral Presentations at the ESMO 2026 in Berlin on MAdCAM-1 as a biomarker in RCC and AI-based generation of synthetic real-world data in oncology respectively.
Our research fellow Clara Steiner served as an Invited Discussant at the ESMO 2025 Congress for the proffered paper session on GU tumours.
September 2025
We're excited to welcome Gaelle Nafeh and Elio Ibrahim to the team as postdoctoral research fellows!
August 2025
Our work on overcoming c-Met-induced therapeutic resistance in renal cell carcinoma by targeting AXL was published in Cancer Letters. LINK
July 2025
Our work on detecting squamous transformation in prostate cancer using plasma epigenomics was published in npj Precision Oncology. LINK
Our work on the role of KIM-1 as a prognostic biomarker in metastatic renal cell carcinoma was published in European Urology focus. LINK
Our work on the tumor-intrinsic and microenvironmental determinants of impaired antitumor immunity in chromophobe renal cell carcinoma was published in the Journal of Clinical Oncology. LINK
News Timeline
November 2025
Congratulations to our postdoctoral research fellow Pablo Moura Barrios for completing the Boston half marathon in support of Dana-Farber and the Jimmy Fund!
October 2025
Our paper showing how myeloid cells mediate interferon-driven resistance to immunotherapy in RCC was published in Immunity. LINK
Our work evaluating humoral immune responses to the second dose of a COVID-19 mRNA vaccine in cancer patients was published in Human Vaccines & Immunotherapeutics. LINK
We're excited to welcome our new postdoctoral research fellow, Sara El Sarout, to the team!
Congratulations to our postdoctoral research fellows Clara Steiner and Marc Machaalani for being selected for Merit Awards for their ESMO 2025 Congress abstracts!
September 2025
We're excited to welcome Gaelle Nafeh and Elio Ibrahim to the team as postdoctoral research fellows!
August 2025
Our work on overcoming c-Met-induced therapeutic resistance in renal cell carcinoma by targeting AXL was published in Cancer Letters. LINK
July 2025
Our work on detecting squamous transformation in prostate cancer using plasma epigenomics was published in npj Precision Oncology. LINK
Our work on the role of KIM-1 as a prognostic biomarker in metastatic renal cell carcinoma was published in European Urology focus. LINK
Our work on the tumor-intrinsic and microenvironmental determinants of impaired antitumor immunity in chromophobe renal cell carcinoma was published in the Journal of Clinical Oncology. LINK
June 2025
Congratulations to Eddy Saad and Karl Semaan on beginning their Internal Medicine residency.
Our work on the impact of comorbidities on the effectiveness of immunotherapy in metastatic renal cell carcinoma was published in Clinical Genitourinary Cancer. LINK
May 2025
Congratulations to our fellows Marc Machaalani and Eddy Saad for being among the recipients of the 2025 ASCO Annual Meeting Conquer Cancer Merit Awards.
April 2025
We're delighted to welcome Weiwei Bian to the team as our computational biologist!
March 2025
Our paper on a personalized neoantigen vaccine for renal cell carcinoma was published in Nature. LINK
A big welcome to our newest research fellow joining the team, Pablo Moura Barrios!
February 2025
Congratulations to our fellows Clara Steiner, Emre Yekedüz, Marc Machaalani, and Rashad Nawfal for being among the recipients of the 2025 Genitourinary Cancers Symposium Conquer Cancer Merit Awards.
January 2025
We are excited to welcome Mustafa Saleh, the new postdoctoral fellow joining the team!
Our paper on progressive natural killer cell dysfunction in advanced-stage clear-cell renal cell carcinoma and association with clinical outcomes was published in ESMO Open. LINK
Our paper on the immunogenomic determinants of exceptional response to immune checkpoint inhibition in renal cell carcinoma was published in Nature Cancer. LINK
December 2024
The Choueiri Lab website is live!
We're delighted that two postdoctoral fellows joined our team – Liliana Ascione and Jad El Masri!
October 2024
A big welcome to the new postdoctoral fellow joining the team – Wassim Daoud Khatoun!
August 2024
Our work on first-line systemic therapy following adjuvant immunotherapy in renal cell carcinoma was published in European Urology. LINK
